We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Bacterial Pneumonia Responds Best to an Antibiotic and Steroid Cocktail

By LabMedica International staff writers
Posted on 21 Oct 2008
Researchers working with a mouse model of bacterial pneumonia have found that treatment with a combination of antibiotic and corticosteroid was more effective than antibiotic treatment alone in curing the disease.

Mycoplasma pneumoniae causes a relatively benign type of respiratory disease that accounts for 20 to 30% of all community-acquired pneumonia cases. More...
Traditionally, infections with M. pneumoniae are treated with antibiotics. However, while this treatment eliminates the causative agent of the respiratory disease, it does not aid in reducing inflammation and swelling in the lungs.

In a study published in the October 15, 2008, issue of the Journal of Infectious Diseases, investigators at the University of Texas Southwestern Medical Center (Dallas, USA) combined traditional antibiotic treatment (in this study clarithromycin) to kill the pathogenic bacteria with corticosteroid treatment to reduce inflammation.

Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex. They are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. The steroid used in this study was dexamethasone.

Mice were infected with M. pneumoniae and then separated into separate treatment groups. Different groups were treated with clarithromycin, dexamethasone, combined clarithromycin/dexamethasone, or a placebo daily. The mice were evaluated at the start of the therapy and after one, three, and six days of treatment.

Results showed that while antibiotic therapy with clarithromycin had the greatest effect on reducing concentrations of M. pneumoniae, combination antibiotic/steroid therapy had the greatest effect on decreasing levels of cytokines and chemokines as well as reducing lung inflammation.

"It turns out that the group that got both the antibiotic and the steroids did the best,” said senior author Dr. Robert Hardy, associate professor of internal medicine and pediatrics at the University of Texas Southwestern Medical Center. "The inflammation in their lungs got significantly better. Some people might think that if you give steroids, it would counteract the effect of the antibiotic, but it turns out you need the antibiotic to kill the bug and the steroid to make the inflammation in the lung from the infection get better. The steroids do not kill the bugs, but they do help restore health.”

Related Links:
University of Texas Southwestern Medical Center



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The automated multiplex PCR assay runs on the BioFire Spotfire Vaginitis System, bringing molecular vaginitis testing to the point of care (Photo courtesy of bioMérieux)

Molecular Vaginitis Panel Gains FDA Clearance and CLIA Waiver for Point-of-Care Use

Vaginitis affects most women at least once in their lifetime and can cause painful, disruptive symptoms. Common causes include bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis, reflecting... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: The CE-marked software IVD combines digital histopathology and clinicopathological data to generate a prognostic classification (Image Credit: Shutterstock)

Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer

In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.